CTRI/2022/02/040450尚未招募2 期
To Observe the Safety and Efficacy of Intradermal Injection of Tranexamic Acid in Patients of Melasma
Dr Meghna Khatri0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients willing to participate in the study.
- •2. Patients of either sex with clinical features of melasma.
- •3. Patients in the age group of 18-60 years.
排除标准
- •1.Patients below the age of 18 years and above the age of 60 years.
- •2.Patients having any other hyperpigmented disorder on the face.
- •3.Patients not willing to participate in the study.
- •4.Pregnant or lactating females.
- •5.Patients with bleeding disorders.
- •6.Patients on anticoagulant therapy.
- •7.Patients having hypersensitivity to tranexamic acid.
- •8.Patients having bilaterally asymmetrical pigmentation.
研究者
相似试验
尚未招募
1 期
Investigating nanofat injection and conditioned medium derived from stem cells in the treatment of androgenic alopeciaHair loss.Nonscarring hair loss, unspecifiedL65.9IRCT20200127046282N34Tehran University of Medical Sciences10
尚未招募
1 期
Investigating the safety and efficacy of injection of fat tissue cells in patients with sclerodermascleroderma.Systemic sclerosis [scleroderma]IRCT20200127046282N35Tehran University of Medical Sciences18
尚未招募
不适用
Comparative study of Intradermal versus Intralesional Purified Protein Derivative (PPD) for treatment of common warts in childreCTRI/2019/07/020070Himachal Pradesh University
尚未招募
1 期
Assessment of the effect of exosomes in the treatment of melasmaIRCT20221130056672N6Tehran University of Medical Sciences30
已完成
不适用
To evaluate the efficacy and safety of subcutaneous and intravenous abatacept.Rheumatoid arthritisJPRN-UMIN000013440Osaka Medical College50